Does CARPERITIDE Cause Thrombotic microangiopathy? 12 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Thrombotic microangiopathy have been filed in association with CARPERITIDE. This represents 14.8% of all adverse event reports for CARPERITIDE.
12
Reports of Thrombotic microangiopathy with CARPERITIDE
14.8%
of all CARPERITIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From CARPERITIDE?
Of the 12 reports, 5 (41.7%) required hospitalization, and 5 (41.7%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARPERITIDE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does CARPERITIDE Cause?
Cardiac failure (15)
Drug ineffective (11)
Hepatic function abnormal (11)
Renal impairment (10)
Blood urea increased (9)
Cardiac failure acute (9)
Weight increased (9)
Blood creatinine increased (8)
Blood alkaline phosphatase increased (7)
Cerebral infarction (7)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)